group II sPLA₂ Antibody (SCACC353): sc-58363

Group II sPLA2 Antibody (SCACC353) is a mouse monoclonal IgG1 kappa light chain antibody that detects group II sPLA2 protein of human origin by western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), and enzyme-linked immunosorbent assay (ELISA). Anti-group II sPLA2 antibody (SCACC353) is available as a non-conjugated format. Group II sPLA2 (SCACC353) antibody recognizes a protein that plays a crucial role in phospholipid hydrolysis, leading to fatty acid release essential for membrane remodeling and signaling pathways. Group II sPLA2 (SCACC353) monoclonal antibody targets an enzyme important in inflammatory responses, generating bioactive lipids that modulate immune cell function. Group II sPLA2 protein interacts with cell membranes, influencing phospholipid metabolism and eicosanoid production, which are signaling molecules involved in inflammation and other physiological responses. The human gene encoding group II sPLA2 is located on chromosome 1, with expression tightly regulated in various tissues, highlighting significance in both normal physiology and pathological conditions.

Alexa Fluor^® is a trademark of Molecular Probes Inc., OR., USA

LI-COR^® and Odyssey^® are registered trademarks of LI-COR Biosciences

group II sPLA₂ Antibody (SCACC353) References:

1. Human pancreatic islets express mRNA species encoding two distinct catalytically active isoforms of group VI phospholipase A2 (iPLA2) that arise from an exon-skipping mechanism of alternative splicing of the transcript from the iPLA2 gene on chromosome 22q13.1.  |  Ma, Z., et al. 1999. J Biol Chem. 274: 9607-16. PMID: 10092647
2. The human calcium-independent phospholipase A2 gene multiple enzymes with distinct properties from a single gene.  |  Larsson Forsell, PK., et al. 1999. Eur J Biochem. 262: 575-85. PMID: 10336645
3. Purification of recombinant human secretory phospholipase A2 (group II) produced in long-term immobilized cell culture.  |  Levin, W., et al. 1992. Protein Expr Purif. 3: 27-35. PMID: 1422206
4. Natural disruption of group 2 phospholipase A2 gene protects against choline-deficient ethionine-supplemented diet-induced acute pancreatitis and lung injury.  |  Kihara, Y., et al. 2005. Pancreas. 31: 48-53. PMID: 15968247
5. The role of phospholipases A2 in schizophrenia.  |  Law, MH., et al. 2006. Mol Psychiatry. 11: 547-56. PMID: 16585943
6. Structures of free and inhibited human secretory phospholipase A2 from inflammatory exudate.  |  Scott, DL., et al. 1991. Science. 254: 1007-10. PMID: 1948070
7. Inhibition of sPLA2 and endothelial function: a substudy of the SPIDER-PCI trial.  |  Lavi, S., et al. 2012. Can J Cardiol. 28: 215-21. PMID: 22281412
8. Role of secretory phospholipase A₂ in women with metabolic syndrome.  |  Pop, D., et al. 2013. Indian J Med Res. 138: 866-72. PMID: 24521628
9. Protective effect of quinacrine against glycerol-induced acute kidney injury in rats.  |  Al Asmari, AK., et al. 2017. BMC Nephrol. 18: 41. PMID: 28129740
10. Secretion of group 2 phospholipase A2 by lacrimal glands.  |  Nevalainen, TJ., et al. 1994. Invest Ophthalmol Vis Sci. 35: 417-21. PMID: 8112989
11. Cloning, chromosomal mapping, and expression of a novel human secretory phospholipase A2.  |  Cupillard, L., et al. 1997. J Biol Chem. 272: 15745-52. PMID: 9188469
12. Crystal structure of human secretory phospholipase A2-IIA complex with the potent indolizine inhibitor 120-1032.  |  Kitadokoro, K., et al. 1998. J Biochem. 123: 619-23. PMID: 9538252